Seroprevalencia del SARS-CoV-2 en los pacientes con enfermedades inmunomediadas en tratamiento con terapias biológicas y sintéticos dirigidos

Romero-Bogado, Liz; Steiner, Martina; Thuissard Vasallo, Israel John; Andreu-Vázquez, Cristina; Cobo-Ibañez, Tatiana; Gómez Gómez, Alejandro; Paredes-Romero, María Beatriz; Esteban-Vázquez, Ana; Cebrián Méndez, Laura; De La Mano, María Ángeles Matías; García-Yubero, Cristina; Martínez Hernández, Alicia; Esteban Ortega, Mar; Manceñido Marcos, Noemí; Pajares, Ramón; Esteban Alba, Concepción; Guillen Santos, Raquel; Navío Marcos, Teresa; Muñoz-Fernández, Santiago.
Rev. chil. infectol ; 40(6): 618-625, dic. 2023. ilus, tab
Artículo en Español | LILACS | ID: biblio-1529991

Documentos relacionados

  1. Reconciling Mouse and Human Immunology at the Altar of Genetics.
  2. Self-Awareness: Nucleic Acid-Driven Inflammation and the Type I Interferonopathies.
  3. Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease.
  4. Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches.
  5. Gene therapy for inborn errors of immunity: Base editing comes into play.
  6. Genetics of Inborn Errors of Immunity in highly consanguineous Middle Eastern and North African populations.
  7. Immune Training Unlocks Innate Potential.
  8. Immunobiology of Long Noncoding RNAs.
  9. Nonredundant roles of basophils in immunity.
  10. Inborn errors of immunity illuminate mechanisms of human immunology and pave the road to precision medicine.